MAA
AERI

Managed Account Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Managed Account Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$994K Sell
56,365
-3,672
-6% -$67.3K ﹤0.01% 2109
2015
Q1 		$1.88M Buy
60,037
+57,268
+2,068% +$1.66M ﹤0.01% 1871
2014
Q4 		$81K Buy
+2,769
New +$70.2K ﹤0.01% 2416

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Managed Account Advisors's AERI Position: Q2 2015 in Review

Managed Account Advisors reduced its Aerie Pharmaceuticals (AERI) stake by 6.1% in Q2 2015, selling an estimated $67.3K and leaving 56,365 shares worth $994K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Managed Account Advisors first reported a position in AERI in Q4 2014 and has held it in 3 quarters since. The position peaked at $1.88M in Q1 2015. 108 funds tracked by Wall St. Rank hold AERI as of Q2 2015.

  • Managed Account Advisors held 56,365 shares of Aerie Pharmaceuticals worth $994K as of Q2 2015.
  • Managed Account Advisors sold 3,672 Aerie Pharmaceuticals shares in Q2 2015, an estimated $67.3K.
  • Aerie Pharmaceuticals made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2109 holding.
  • Managed Account Advisors first reported a position in Aerie Pharmaceuticals in Q4 2014 and has held it in 3 quarters since.
  • Managed Account Advisors's Aerie Pharmaceuticals position peaked at $1.88M in Q1 2015.
  • 108 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.